The UK Competition & Markets Authority on Monday said it will not progress a probe into CVS’s purchase of Quality Pet Care after the London-listed firm agreed to offload the business in question, in response to competition concerns raised by the CMA.
In August 2021, Norfolk-based veterinary services firm CVS announced its acquisition of Quality Pet Care, which trades as The Vet, for GBP20.4 million.
However, in September, the CMA opened an investigation into the deal, and in February had judged that the acquisition would reduce competition in Bristol, Nottingham, Portsmouth, Southampton and Warrington. It said it would refer the deal for an in-depth investigation unless CVS offered acceptable remedies for the regulator’s concerns.
In response, CVS offered to divest the entire The Vet business – a solution the CMA on Monday said it had accepted.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
TikTok and ByteDance File Lawsuit Against US Law Mandating App Sale
May 7, 2024 by
CPI
Apollo, Sony Bid to Acquire Paramount Faces Regulatory Hurdles
May 7, 2024 by
CPI
Turkey Fines Meta $10.4 Million for Abusing Market Dominance
May 6, 2024 by
CPI
Canadian Watchdog Launches Inquiry into Lululemon’s Greenwashing Practices
May 6, 2024 by
CPI
Massachusetts Supreme Court Deliberates On Ballot Redefining Gig Worker Status
May 6, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI